Cargando…
A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: balancing the risks and benefits
Atrial fibrillation (AF) puts patients at risk of complications, including stroke. Warfarin therapy has been the mainstay of antithrombotic treatment for reducing the risk of stroke in AF. However, warfarin has limitations that have motivated development of several novel oral anticoagulants (NOACs),...
Autores principales: | Amin, Alpesh, Deitelzweig, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546218/ https://www.ncbi.nlm.nih.gov/pubmed/26300695 http://dx.doi.org/10.1186/s12959-015-0056-y |
Ejemplares similares
-
Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks
por: Deitelzweig, Steve, et al.
Publicado: (2013) -
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin, Alpesh
Publicado: (2013) -
Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)
por: Coll-Vinent, Blanca, et al.
Publicado: (2017) -
Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
por: Armaganijan, Luciana, et al.
Publicado: (2012) -
Stroke prevention in atrial fibrillation: comparison of recent international guidelines
por: Chao, Tze-Fan, et al.
Publicado: (2020)